The role of mitochondria is vital to cellular processes to immune function, and the evidence for the immunological dysfunction of mitochondrial diseases continues to grow. Infection stands as a prominent cause of morbidity in mitochondrial diseases, which leads to acidosis and organ dysfunction/failure, often in a rapid and fatal progression. Understanding this, the infection risk of the population with mitochondrial dysfunction must be evaluated and treated accurately. Regarding the problems posed by infections that are linked to mitochondrial diseases, Protheragen is devoted to providing holistic services for vaccine development.
Our Services
Protheragen has vast experience in molecular biology, immunology, and preclinical evaluation guiding the multidisciplinary team to achieve all-encompassing vaccine development services.
Vaccine Efficacy
Studies
We carry out preclinical investigations based on mitochondrial disease models to measure the effectiveness of vaccines and their immune response capabilities against certain pathogens.
Immunogenicity Assessments
Evaluate the effectiveness of vaccination by measuring the immune responses of models with mitochondrial diseases through serum antibody titers and assessing the immune system's ability.
Vaccine Safety Evaluations
Complete safety assessments of vaccines meant for subjects having mitochondrial diseases with regards to their particular immune profile for the possible risks of vaccine administration.
Our Advantages
Professional Team
Advanced Technology
Comprehensive Services
Reliable Data and Results
A group of specialists at Protheragen blends experience in mitochondrial disorders and vaccine construction, allowing us to ensure that services are tailored with precision to solve the problems presented by mitochondrial diseases. Please do not hesitate to contact us so that you take advantage of our knowledge and help in developing novel vaccines that aim to shield mitochondrial disorders from manageable infections.
